Skip to content

Diagnostic Criteria of ARDS at High Altitudes in Western China

Diagnostic Criteria of ARDS at High Altitudes in Western China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04215666
Enrollment
3000
Registered
2020-01-02
Start date
2019-12-01
Completion date
2022-12-31
Last updated
2020-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Keywords

ARDS, Definitions, high-altitude

Brief summary

The severity of ARDS in high altitude areas was classified according to the Berlin standard high altitude area Oxygenation.

Detailed description

Will between January 2018 and December 2018 in lanzhou, and so on more than 1500 meters above sea level in qinghai region 10 intensive care patients with ARDS, respectively according to the standard in Berlin, Berlin, diagnosis of high altitude ARDS calibration standards and zhang the plateau region in western China put forward by the diagnosis of ALI/ARDS severity classification, observation group patients were ICU mortality, within 28 days, ICU mortality did not use breathing machine time, mechanical ventilation, ICU length of hospital stay, and the differences in hospitalization days.

Interventions

None listed

Sponsors

Children's Hospital of Fudan University
CollaboratorOTHER
Affiliated Hospital of Qinghai University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age ≥18 * the primary disease of ARDS caused by systemic infection, shock, severe pneumonia, aspiration and trauma * blood gas analysis showed a progressive decline in pulmonary ventilation function * PEEP≥5cmH2O

Exclusion criteria

* Receive a large amount of hormone shock therapy in a short period of time * Died within a short time (\< 24h) after mechanical ventilation * Lack of data * No chest imaging data

Design outcomes

Primary

MeasureTime frameDescription
ICU mortalityup to 24 weeksmortality during treatment in ICU
28 days mortalityup to 24 weeksmortality at 28 days of hospitalization

Secondary

MeasureTime frameDescription
Ventilator Free timeup to 24 weeksNo ventilator use time in ICU
Ventilator timeup to 24 weeksVentilator time in ICU

Countries

China

Contacts

Primary ContactGan Guifen, Bachelor
xzhd1991@163.com15897083336
Backup ContactPan Chun, Doctor
panchun1982@gmail.com13814009925

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026